Loading...
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and eff...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658444/ https://ncbi.nlm.nih.gov/pubmed/26635807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00593 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|